P3.01-073 TPX-0005 with an EGFR Tyrosine Kinase Inhibitor (TKI) Overcomes Innate Resistance in EGFR Mutant NSCLC

Autor:	S. Ignatius Ou, Jean Cui, X. Li, Peng Cao, J.M. Sánchez-Torres, A. Vergnenegre, Ana Giménez-Capitán, R. Garcia Campelo, Guillermo Lopez-Vivanco, Rosa Rosell, Antonio Passaro, J.C.-H. Yang, Jordi Berenguer, C. Codony Servat, J. Bratch, Enric Carcereny, A. Cardona, Santiago Viteri, M. Provencio, Imane Chaib, M.A. Molina-Vila, F. De Marinis, Noemí Reguart, Niki Karachaliou, J. Codony Servat, Ana Drozdowskyj
Rok vydání:	2017
Předmět:	Pulmonary and Respiratory Medicine Oncology business.industry Mutant Cancer research Medicine business Egfr tyrosine kinase
Zdroj:	Journal of Thoracic Oncology. 12:S2230
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2017.09.1514
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6e9ef0b605bd684bcb64f42a70ab6ef7 https://doi.org/10.1016/j.jtho.2017.09.1514 Zobrazit plný text záznamu